Dec 16, 2022 | Featured, Medicare
Patients Rising Now joined 50 other organizations in a letter to President Biden requesting that he direct HHS Secretary Becerra to reopen the National Coverage Determination (NCD) on PET scans for patients participating in Alzheimer’s treatments trials. CMS’ current...
Read more
Jul 18, 2022 | Comment Letters
The Centers for Medicare and Medicaid (CMS) recently held a comment period as they reconsidered limitations on scans to detect Dementia. The current system only allows for a single PET scan to be covered by CMS for an Alzheimer’s patient enrolled in a clinical...
Read more
Apr 9, 2022 | Access, Featured
On this episode of the podcast, Terry and Bob discuss the access and affordability challenges that patients with Alzheimer’s and diabetes face. They highlight a new analysis that concludes an enormous $350 billion of prescription drug rebates were spent last...
Read more
Apr 9, 2022 | Access, Featured
WASHINGTON — Patients Rising Now Executive Director Terry Wilcox today released the following statement in response to CMS’ final decision to restrict access to FDA-approved Alzheimer’s treatments to clinical trial participants: “It’s a sad day for the millions...
Read more
Jan 14, 2022 | Public Statement
Proposed decision will Exacerbate Health Inequities, Undermine FDA WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding the Centers for Medicare and Medicaid Service proposed decision on the national coverage...
Read more
